Aside from its pivotal functions in embryonic development and tissue organization, in vitro and in vivo experiments have indicated that ITGB4 promotes tumorigenesis and metastasis in a broad range of solid tumors, including breast cancer, prostate cancer, lung cancer and pancreatic cancer, by triggering downstream signaling. Here, ITGB4 is linked to prostate carcinoma.